November 18, 2021 12:13 PM EST
Manufacturing

South Ko­re­an drug­mak­er SK looks to take over Philly CD­MO's op­er­a­tions

Josh Sullivan

The hold­ing com­pa­ny of a South Ko­re­an vac­cine mak­er is in the fi­nal talks to make an in­vest­ment in­to a US gene ther­a­py firm. …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

Sion­na and Odyssey end JPM week with IPO fil­ings

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times